Why We Need Treatments Beyond Just CPAP
Positive airway pressure therapy isn't for everyone, says AASM award winner Richard Berry, MD, FAASM, who also shares his insights on positional therapies, neurostimulation, and interface selection.
Category: Neurostimulators
Neurostimulators
Latest
Neurostimulators
Latest
Investigational Nerve Stimulator for Obstructive Sleep Apnea: Surgical Technique Description and Case Study Report Published
Data demonstrating the benefits and safety of Nyxoah SA’s Genio hypoglossal nerve...
Neurostimulators
Popular
Which Patients Are Good Candidates for Inspire Upper Airway Stimulation?
As the first FDA-cleared fully implanted neurostimulation device for obstructive sleep apnea becomes available in additional cities throughout the United States, Sleep Review provides guidance on how to screen patients for this therapy.
Company Closes Series 2 Funding Round for Continued Development of Daytime Neurostimulator for Snoring, Mild Sleep Apnea
Signifier Medical Technologies, which is developing the “Snoozeal” daytime...
Read More
Therapy Update: Implanted Neurostimulators for Sleep Apnea
Inspire Medical, Respicardia, LivaNova, and Nyxoah share the latest data on their devices. By Sree...
Read More
More Positive Payor Determinations for Inspire Therapy, Including Additional 10.4 Million Covered Lives
Inspire Medical Systems Inc, a medical technology company that makes an implantable therapy for...
Read More
Upper Airway Stimulation’s Impact on Sleep Apnea Comorbidities
The Inspire implant has been shown to improve sleepiness and functional outcomes. Now researchers...
Read MoreNyxoah Gets European CE Mark Approval for Sleep Apnea Hypoglossal Nerve Stimulation System
Nyxoah SA has received CE Mark approval for the Genio system in Europe. The Genio system is a battery-free, leadless and minimally invasive neurostimulator, capable of delivering bilateral hypoglossal nerve stimulation for...
Read MoreFDA Approves Inspire’s Smaller Profile Sensing Lead for Implanted Neurostimulator
The US Food and Drug Administration (FDA) has approved for use in the United States Inspire Medical Systems Inc’s new sensing lead. Inspire intends to introduce the new sensing lead to its US medical center customers in...
Read MoreInteger Supports Respicardia’s Commercialization in Central Sleep Apnea Market Through New Agreements
Integer, a leading medical device outsource manufacturer, has entered into a new development agreement and a new supply agreement with Respicardia Inc. Under the agreements, Integer will be Respicardia’s development partner and...
Read MoreBlue Cross of Idaho Issues Positive Coverage Policy of Inspire Therapy
Blue Cross of Idaho has issued a positive coverage policy of Inspire Medical Systems Inc’s Inspire upper airway stimulation therapy for obstructive sleep apnea. This is the first coverage policy issued following BCBS...
Read MoreBlue Cross Blue Shield Association’s Evidence Street Issues Positive Assessment for Inspire Therapy
Inspire Medical Systems Inc, a medical technology company that makes an implantable therapy for obstructive sleep apnea (OSA) and is focused on the development and commercialization of minimally invasive solutions for patients...
Read MoreNyxoah Raises €15 Million in New Financing, Completes BLAST OSA Clinical Study
Nyxoah SA, a medical device company focused on the development and commercialization of a hypoglossal nerve stimulation (HGNS) therapy for the treatment of obstructive sleep apnea (OSA), has raised an additional €15 million...
Read More
CMS Grants Outpatient Pass-through Payment to Remedē System for Central Sleep Apnea
The Centers for Medicare and Medicaid Services (CMS) has approved an outpatient Transitional...
Read MoreHypoglossal Nerve Stimulation in OSA: A Viable Alternative to CPAP
Although nasal continuous positive airway pressure (CPAP) is recommended as the first-line treatment for most patients with obstructive sleep apnea (OSA), and its efficacy is well-supported, there is a high rate of nonadherence...
Read MoreIn Europe, Inspire Medical Implants New Sensing Lead
Inspire Medical Systems Inc, a medical technology company that makes an implantable therapy for obstructive sleep apnea (OSA) and is focused on the development and commercialization of minimally invasive solutions for patients...
Read MoreInspire Medical Systems to Host Symposium, Training Program for Sleep Apnea Device at AAO-HNSF Annual Meeting
Inspire Medical Systems Inc, a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea (OSA), will have a presence at...
Read More
CMS Grants “New Technology Add-on Payment” to Remedē System for Treatment of Central Sleep Apnea
The Centers for Medicare and Medicaid Services (CMS) has approved a “New Technology Add-On...
Read More